Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robyn T Domsic

Showing results (31-40 of 94) with videos related to

Pageof 10
Sort By:
Arthritis Care & Research|September 23, 2018
Anti-RNPC-3 (U11/U12) Antibodies in Systemic Sclerosis in Patients With Moderate-to-Severe Gastrointestinal DysmotilityZsuzsanna H McMahan, Robyn T Domsic, Lei Zhu, et al.
Human Pathology|November 1, 2008
Renal biopsy findings predicting outcome in scleroderma renal crisisIbrahim Batal, Robyn T Domsic, Aaron Shafer, et al.
Rheumatology (Oxford, England)|January 28, 2021
Defining the optimal disease duration of early diffuse systemic sclerosis for clinical trial designRobyn T Domsic, Shiyao Gao, Maureen Laffoon, et al.
The Journal of Investigative Dermatology|December 26, 2016
Skin-Resident Effector Memory CD8<sup>+</sup>CD28<sup>-</sup> T Cells Exhibit a Profibrotic Phenotype in Patients with Systemic SclerosisGang Li, Adriana T Larregina, Robyn T Domsic, et al.
NPJ Digital Medicine|June 18, 2026
Unlocking multi-institutional insights into disease progression with PEAL as a lossless, one-shot federated learning solutionYicheng Shen, Ji Soo Kim, Chongliang Luo, et al.
Arthritis and Rheumatism|July 1, 2009
Anti-U11/U12 RNP antibodies in systemic sclerosis: a new serologic marker associated with pulmonary fibrosisNoreen Fertig, Robyn T Domsic, Tatiana Rodriguez-Reyna, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 20, 2015
Association Between Initial Oral Therapy and Outcomes in Systemic Sclerosis-Related Pulmonary Arterial HypertensionMatthew R Lammi, Stephen C Mathai, Lesley Ann Saketkoo, et al.
Arthritis Care & Research|July 14, 2025
Late-Onset Scleroderma Renal Crisis Does Occur - A Multi-Center StudySwati Mehta, Sumbal Wajid, Isam Albaba, et al.
Seminars in Arthritis and Rheumatism|June 21, 2025
Comparing Raynaud's phenomenon attack measurement tools: paper or smartphone application?Rachel S Wallwork, Haomin Hu, Ami A Shah, et al.
Rheumatology (Oxford, England)|August 29, 2022
A data-driven approach finds RNA polymerase III antibody and tendon friction rubs as enrichment tools for early diffuse scleroderma trialsRobyn T Domsic, Thomas A Medsger, Shiyao Gao, et al.
Pageof 10

Showing results (31-40 of 94) with videos related to

Sort By:
Pageof 10
Arthritis Care & Research|September 23, 2018
Anti-RNPC-3 (U11/U12) Antibodies in Systemic Sclerosis in Patients With Moderate-to-Severe Gastrointestinal DysmotilityZsuzsanna H McMahan, Robyn T Domsic, Lei Zhu, et al.
Human Pathology|November 1, 2008
Renal biopsy findings predicting outcome in scleroderma renal crisisIbrahim Batal, Robyn T Domsic, Aaron Shafer, et al.
Rheumatology (Oxford, England)|January 28, 2021
Defining the optimal disease duration of early diffuse systemic sclerosis for clinical trial designRobyn T Domsic, Shiyao Gao, Maureen Laffoon, et al.
The Journal of Investigative Dermatology|December 26, 2016
Skin-Resident Effector Memory CD8<sup>+</sup>CD28<sup>-</sup> T Cells Exhibit a Profibrotic Phenotype in Patients with Systemic SclerosisGang Li, Adriana T Larregina, Robyn T Domsic, et al.
NPJ Digital Medicine|June 18, 2026
Unlocking multi-institutional insights into disease progression with PEAL as a lossless, one-shot federated learning solutionYicheng Shen, Ji Soo Kim, Chongliang Luo, et al.
Arthritis and Rheumatism|July 1, 2009
Anti-U11/U12 RNP antibodies in systemic sclerosis: a new serologic marker associated with pulmonary fibrosisNoreen Fertig, Robyn T Domsic, Tatiana Rodriguez-Reyna, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 20, 2015
Association Between Initial Oral Therapy and Outcomes in Systemic Sclerosis-Related Pulmonary Arterial HypertensionMatthew R Lammi, Stephen C Mathai, Lesley Ann Saketkoo, et al.
Arthritis Care & Research|July 14, 2025
Late-Onset Scleroderma Renal Crisis Does Occur - A Multi-Center StudySwati Mehta, Sumbal Wajid, Isam Albaba, et al.
Seminars in Arthritis and Rheumatism|June 21, 2025
Comparing Raynaud's phenomenon attack measurement tools: paper or smartphone application?Rachel S Wallwork, Haomin Hu, Ami A Shah, et al.
Rheumatology (Oxford, England)|August 29, 2022
A data-driven approach finds RNA polymerase III antibody and tendon friction rubs as enrichment tools for early diffuse scleroderma trialsRobyn T Domsic, Thomas A Medsger, Shiyao Gao, et al.
Pageof 10